Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Aspen Adrenaline
Active Ingredient:	Adrenaline 1mg
Dosage Form:	Solution for injection
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:	Biologici Italia Laboratoires Srl, Milan, Italy Steriscience Sp. z o.o., Warszawa, Poland

*Product:*	Aspen Adrenaline
Active Ingredient:	Adrenaline 1mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:	Biologici Italia Laboratoires Srl, Milan, Italy Steriscience Sp. z o.o., Warszawa, Poland

*Product:*	Biktarvy
Active Ingredients:	Bictegravir sodium 52.45mg equivalent to bictegravir 50mg Emtricitabine 200mg Tenofovir alafenamide fumarate 28.04mg equivalent to tenofovir alafenamide 25mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Gilead Sciences (NZ)
Manufacturers:	Rottendorf Pharma GmbH, Ennigerloh, Germany Gilead Sciences Ireland UC, Carrigtohill, Ireland

*Product:*	Menopur
Active Ingredient:	Menotrophin 75IU equivalent to FSH 75IU and LH 75IU
Dosage Form:	Powder for injection
Dosage Form:	Diluent
New Zealand Sponsor:	Pharmaco (NZ) Limited
Manufacturers:	Ferring GmbH, Kiel, Germany Ferring Production Inc., New Jersey, United States of America

Dated this 19th day of December 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule